Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Chemotherapy is a type of cancer treatment which involves the use of one or more chemotherapeutic agents such as anti-cancer drugs. The treatment prevents the cancer cells division and growth of cancer cells by killing the dividing cells. It is used for the treatment of various types of cancer such as lung cancer, breast cancer, leukemia, myeloma, sarcoma, lymphoma, ovarian cancer, and others.
This report elaborates on the current development of the Chemotherapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Spectrum Pharmaceuticals, Inc
Immunomedics, Inc
GlaxoSmithKline PIC
Abbott Laboratories
Indevus Pharmaceuticals Inc
Sanofi-Aventis SA
Dendreon Corporation
AstraZeneca PlC
Progenics Pharmaceuticals, Inc
Novartis AG (Switzerland)
F Hoffmann-La Roche Ltd
ALZA Corporation
Genentech Inc
Takeda Pharmaceutical Company
Amgen Inc
Bristol-Myers Squibb Company
Medimmune, LLC
Cell Genesys Inc
EUSA Pharma, Inc
By Type:
Paclitaxel
Others
Vincristine
By Application:
Hospitals
Others
Research institutes
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Chemotherapy Market Overview 2018-2029
-
1.1 China Chemotherapy Industry Development Overview
-
1.2 China Chemotherapy Industry Development History
-
1.3 China Chemotherapy Industry Market Size (2018-2029)
-
1.4 China Chemotherapy Market Analysis by Type from Production Side
-
1.4.1 China Chemotherapy Production Volume, Production Value and Growth Rate of Paclitaxel (2018-2029)
-
1.4.2 China Chemotherapy Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Chemotherapy Production Volume, Production Value and Growth Rate of Vincristine (2018-2029)
-
1.5 China Chemotherapy Market Analysis by Application from Consumption End
-
1.5.1 China Chemotherapy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Chemotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Chemotherapy Sales Volume, Sales Value and Growth Rate of Research institutes (2018-2029)
-
1.6 China Chemotherapy Market Analysis by Region
-
1.6.1 North China Chemotherapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Chemotherapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Chemotherapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Chemotherapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Chemotherapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Chemotherapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Chemotherapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Chemotherapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Chemotherapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Chemotherapy Market Status and Competition Analysis in 2023
-
2.2.3 China Chemotherapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Chemotherapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Chemotherapy Industry Development
Chapter 3 ChemotherapyIndustry Chain Analysis
-
3.1 Chemotherapy Industry Chain
-
3.2 Chemotherapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Chemotherapy Market
-
3.3 Chemotherapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Chemotherapy Market
Chapter 4 China Chemotherapy Market, by Type
-
4.1 China Chemotherapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Chemotherapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Chemotherapy Production Volume and Growth Rate, by Type
-
4.5.1 China Chemotherapy Production Volume and Growth Rate of Paclitaxel
-
4.5.2 China Chemotherapy Production Volume and Growth Rate of Others
-
4.5.3 China Chemotherapy Production Volume and Growth Rate of Vincristine
Chapter 5 China Chemotherapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Chemotherapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Chemotherapy Market Size and Growth Rate, by Application
-
5.5.1 China Chemotherapy Market Size and Growth Rate of Hospitals
-
5.5.2 China Chemotherapy Market Size and Growth Rate of Others
-
5.5.3 China Chemotherapy Market Size and Growth Rate of Research institutes
Chapter 6 China Chemotherapy Market, by Region
-
6.1 China Chemotherapy Production Volume and Production Value, by Region
-
6.2 China Chemotherapy Sales Volume and Sales Value, by Region
Chapter 7 North China Chemotherapy Market Analysis
-
7.1 North China Chemotherapy Market, by Type
-
7.2 North China Chemotherapy Market, by Application
Chapter 8 Central China Chemotherapy Market Analysis
-
8.1 Central China Chemotherapy Market, by Type
-
8.2 Central China Chemotherapy Market, by Application
Chapter 9 South China Chemotherapy Market Analysis
-
9.1 South China Chemotherapy Market, by Type
-
9.2 South China Chemotherapy Market, by Application
Chapter 10 East China Chemotherapy Market Analysis
-
10.1 East China Chemotherapy Market, by Type
-
10.2 East China Chemotherapy Market, by Application
Chapter 11 Northeast China Chemotherapy Market Analysis
-
11.1 Northeast China Chemotherapy Market, by Type
-
11.2 Northeast China Chemotherapy Market, by Application
Chapter 12 Southwest China Chemotherapy Market Analysis
-
12.1 Southwest China Chemotherapy Market, by Type
-
12.2 Southwest China Chemotherapy Market, by Application
Chapter 13 Northwest China Chemotherapy Market Analysis
-
13.1 Northwest China Chemotherapy Market, by Type
-
13.2 Northwest China Chemotherapy Market, by Application
Chapter 14 Company Profiles
-
14.1 Spectrum Pharmaceuticals, Inc
-
14.1.1 Spectrum Pharmaceuticals, Inc Company Profile
-
14.1.2 Spectrum Pharmaceuticals, Inc Chemotherapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Immunomedics, Inc
-
14.2.1 Immunomedics, Inc Company Profile
-
14.2.2 Immunomedics, Inc Chemotherapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 GlaxoSmithKline PIC
-
14.3.1 GlaxoSmithKline PIC Company Profile
-
14.3.2 GlaxoSmithKline PIC Chemotherapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Abbott Laboratories
-
14.4.1 Abbott Laboratories Company Profile
-
14.4.2 Abbott Laboratories Chemotherapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Indevus Pharmaceuticals Inc
-
14.5.1 Indevus Pharmaceuticals Inc Company Profile
-
14.5.2 Indevus Pharmaceuticals Inc Chemotherapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Sanofi-Aventis SA
-
14.6.1 Sanofi-Aventis SA Company Profile
-
14.6.2 Sanofi-Aventis SA Chemotherapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Dendreon Corporation
-
14.7.1 Dendreon Corporation Company Profile
-
14.7.2 Dendreon Corporation Chemotherapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 AstraZeneca PlC
-
14.8.1 AstraZeneca PlC Company Profile
-
14.8.2 AstraZeneca PlC Chemotherapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Progenics Pharmaceuticals, Inc
-
14.9.1 Progenics Pharmaceuticals, Inc Company Profile
-
14.9.2 Progenics Pharmaceuticals, Inc Chemotherapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Novartis AG (Switzerland)
-
14.10.1 Novartis AG (Switzerland) Company Profile
-
14.10.2 Novartis AG (Switzerland) Chemotherapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 F Hoffmann-La Roche Ltd
-
14.11.1 F Hoffmann-La Roche Ltd Company Profile
-
14.11.2 F Hoffmann-La Roche Ltd Chemotherapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 ALZA Corporation
-
14.12.1 ALZA Corporation Company Profile
-
14.12.2 ALZA Corporation Chemotherapy Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Genentech Inc
-
14.13.1 Genentech Inc Company Profile
-
14.13.2 Genentech Inc Chemotherapy Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Takeda Pharmaceutical Company
-
14.14.1 Takeda Pharmaceutical Company Company Profile
-
14.14.2 Takeda Pharmaceutical Company Chemotherapy Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Amgen Inc
-
14.15.1 Amgen Inc Company Profile
-
14.15.2 Amgen Inc Chemotherapy Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Bristol-Myers Squibb Company
-
14.16.1 Bristol-Myers Squibb Company Company Profile
-
14.16.2 Bristol-Myers Squibb Company Chemotherapy Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Medimmune, LLC
-
14.17.1 Medimmune, LLC Company Profile
-
14.17.2 Medimmune, LLC Chemotherapy Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Cell Genesys Inc
-
14.18.1 Cell Genesys Inc Company Profile
-
14.18.2 Cell Genesys Inc Chemotherapy Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 EUSA Pharma, Inc
-
14.19.1 EUSA Pharma, Inc Company Profile
-
14.19.2 EUSA Pharma, Inc Chemotherapy Market Performance
-
14.19.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Chemotherapy Industry Research Conclusions
-
15.2 Chemotherapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Chemotherapy Industry Market Size (2018-2029)
-
Figure China Chemotherapy Production Volume, Production Value and Growth Rate of Paclitaxel (2018-2029)
-
Figure China Chemotherapy Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Chemotherapy Production Volume, Production Value and Growth Rate of Vincristine (2018-2029)
-
Figure China Chemotherapy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Chemotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Chemotherapy Sales Volume, Sales Value and Growth Rate of Research institutes (2018-2029)
-
Figure North China Chemotherapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Chemotherapy Market Size and Growth Rate from 2018-2029
-
Figure South China Chemotherapy Market Size and Growth Rate from 2018-2029
-
Figure East China Chemotherapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Chemotherapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Chemotherapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Chemotherapy Market Size and Growth Rate from 2018-2029
-
Figure Chemotherapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Chemotherapy Market Share by Type in 2018
-
Figure China Chemotherapy Market Share by Type in 2023
-
Figure China Chemotherapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Chemotherapy Production Volume and Growth Rate of Paclitaxel (2018-2023)
-
Figure China Chemotherapy Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Chemotherapy Production Volume and Growth Rate of Vincristine (2018-2023)
-
Figure China Chemotherapy Market Share by Application in 2018
-
Figure China Chemotherapy Market Share by Application in 2023
-
Figure China Chemotherapy Total Market Size and Growth Rate from Consumption End
-
Figure China Chemotherapy Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Chemotherapy Market Size and Growth Rate of Others (2018-2023)
-
Figure China Chemotherapy Market Size and Growth Rate of Research institutes (2018-2023)
-
Table China Chemotherapy Production Volume by Region (2018-2023)
-
Table China Chemotherapy Production Volume Share by Region (2018-2023)
-
Figure China Chemotherapy Production Volume Share by Region (2018-2023)
-
Table China Chemotherapy Production Value by Region (2018-2023)
-
Table China Chemotherapy Production Value Share by Region (2018-2023)
-
Figure China Chemotherapy Production Value Share by Region (2018-2023)
-
Table China Chemotherapy Sales Volume by Region (2018-2023)
-
Table China Chemotherapy Sales Volume Share by Region (2018-2023)
-
Figure China Chemotherapy Sales Volume Share by Region (2018-2023)
-
Table China Chemotherapy Sales Value by Region (2018-2023)
-
Table China Chemotherapy Sales Value Share by Region (2018-2023)
-
Figure China Chemotherapy Sales Value Share by Region (2018-2023)
-
Table North China Chemotherapy Production Volume by Type (2018-2023)
-
Table North China Chemotherapy Production Volume Share by Type (2018-2023)
-
Figure North China Chemotherapy Production Volume Share by Type (2018-2023)
-
Table North China Chemotherapy Sales Volume by Application (2018-2023)
-
Table North China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Figure North China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Table Central China Chemotherapy Production Volume by Type (2018-2023)
-
Table Central China Chemotherapy Production Volume Share by Type (2018-2023)
-
Figure Central China Chemotherapy Production Volume Share by Type (2018-2023)
-
Table Central China Chemotherapy Sales Volume by Application (2018-2023)
-
Table Central China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Table South China Chemotherapy Production Volume by Type (2018-2023)
-
Table South China Chemotherapy Production Volume Share by Type (2018-2023)
-
Figure South China Chemotherapy Production Volume Share by Type (2018-2023)
-
Table South China Chemotherapy Sales Volume by Application (2018-2023)
-
Table South China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Figure South China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Table East China Chemotherapy Production Volume by Type (2018-2023)
-
Table East China Chemotherapy Production Volume Share by Type (2018-2023)
-
Figure East China Chemotherapy Production Volume Share by Type (2018-2023)
-
Table East China Chemotherapy Sales Volume by Application (2018-2023)
-
Table East China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Figure East China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Chemotherapy Production Volume by Type (2018-2023)
-
Table Northeast China Chemotherapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Chemotherapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Chemotherapy Sales Volume by Application (2018-2023)
-
Table Northeast China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Chemotherapy Production Volume by Type (2018-2023)
-
Table Southwest China Chemotherapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Chemotherapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Chemotherapy Sales Volume by Application (2018-2023)
-
Table Southwest China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Chemotherapy Production Volume by Type (2018-2023)
-
Table Northwest China Chemotherapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Chemotherapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Chemotherapy Sales Volume by Application (2018-2023)
-
Table Northwest China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Chemotherapy Sales Volume Share by Application (2018-2023)
-
Table Spectrum Pharmaceuticals, Inc Company Profile
-
Table Spectrum Pharmaceuticals, Inc Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Immunomedics, Inc Company Profile
-
Table Immunomedics, Inc Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline PIC Company Profile
-
Table GlaxoSmithKline PIC Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Abbott Laboratories Company Profile
-
Table Abbott Laboratories Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Indevus Pharmaceuticals Inc Company Profile
-
Table Indevus Pharmaceuticals Inc Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Sanofi-Aventis SA Company Profile
-
Table Sanofi-Aventis SA Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Dendreon Corporation Company Profile
-
Table Dendreon Corporation Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca PlC Company Profile
-
Table AstraZeneca PlC Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Progenics Pharmaceuticals, Inc Company Profile
-
Table Progenics Pharmaceuticals, Inc Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Novartis AG (Switzerland) Company Profile
-
Table Novartis AG (Switzerland) Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table ALZA Corporation Company Profile
-
Table ALZA Corporation Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Genentech Inc Company Profile
-
Table Genentech Inc Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceutical Company Company Profile
-
Table Takeda Pharmaceutical Company Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Amgen Inc Company Profile
-
Table Amgen Inc Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Company Profile
-
Table Bristol-Myers Squibb Company Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Medimmune, LLC Company Profile
-
Table Medimmune, LLC Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table Cell Genesys Inc Company Profile
-
Table Cell Genesys Inc Chemotherapy Revenue, Price and Gross (2018-2023)
-
Table EUSA Pharma, Inc Company Profile
-
Table EUSA Pharma, Inc Chemotherapy Revenue, Price and Gross (2018-2023)
-
